Search icon

HARMONY BIOSCIENCES MANAGEMENT, INC.

Company claim

Is this your business?

Get access!

Company Details

Name: HARMONY BIOSCIENCES MANAGEMENT, INC.
Legal type: Foreign Corporation
Status: Active
Standing: Good
Profit or Non-Profit: Profit
File Date: 27 Jul 2007 (18 years ago)
Authority Date: 27 Jul 2007 (18 years ago)
Last Annual Report: 25 Jul 2024 (10 months ago)
Organization Number: 0669725
Industry: Business Services
Number of Employees: Small (0-19)
Principal Office: 630 W. Germantown Pike , Suite 215, Plymouth Meeting, PA 19462
Place of Formation: DELAWARE

Director

Name Role
Sandip Kapadia Director

President

Name Role
Sandip Kapadia President

Registered Agent

Name Role
CT CORPORATION SYSTEM Registered Agent

Secretary

Name Role
Christian Ulrich Secretary

Form 5500 Series

Employer Identification Number (EIN):
260389433
Plan Year:
2013
Number Of Participants:
7
Sponsors Telephone Number:
Plan Year:
2012
Number Of Participants:
8
Sponsors Telephone Number:
Plan Year:
2011
Number Of Participants:
5
Sponsors Telephone Number:
Plan Year:
2010
Number Of Participants:
6
Sponsors Telephone Number:
Plan Year:
2010
Number Of Participants:
6
Sponsors Telephone Number:

Permits

Agency Interest Id Program Activity Type Current Milestone Issued Date Milestone Date
113331 Air Registered Source-Initial Approval Issued 2012-07-10 2012-07-10
Document Name AreaSourceLetter.DOC
Date 2012-07-13
Document Download

Former Company Names

Name Action
ZYNERBA PHARMACEUTICALS, INC. Old Name
ALLTRANZ INC. Old Name

Filings

Name File Date
Amended Cert of Authority 2024-09-04
Principal Office Address Change 2024-07-25
Annual Report 2024-07-25
Principal Office Address Change 2024-07-25
Annual Report 2024-07-25

USAspending Awards / Contracts

Procurement Instrument Identifier:
HHSF223200811062P
Award Or Idv Flag:
AWARD
Award Type:
PO
Action Obligation:
99800.00
Base And Exercised Options Value:
99800.00
Base And All Options Value:
99800.00
Awarding Agency Name:
Department of Health and Human Services
Performance Start Date:
2008-06-02
Description:
THE EFFECT OF OCCLUSION OVERLAYS ON THE PERCUTANEOUS ABSORPTION OF DRUGS
Naics Code:
541690: OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES
Product Or Service Code:
R499: OTHER PROFESSIONAL SERVICES

USAspending Awards / Financial Assistance

Date:
2012-07-26
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
TRANSDERMAL NALTREXONE FOR OPIATE ADDICTION AND ALCOHOLISM
Obligated Amount:
579863.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2012-07-11
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
MICRONEEDLE-ENHANCED CODRUG DELIVERY FOR SMOKING CESSATION AND APPETITE SUPPRESSI
Obligated Amount:
416060.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2011-07-14
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
TRANSDERMAL CANNABIDIOL PRODRUG DELIVERY
Obligated Amount:
160500.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2009-09-30
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
TRANSDERMAL CANNABINOID PRODRUG TREATMENT FOR CANNABIS WITHDRAWAL AND DEPENDENCE
Obligated Amount:
4013265.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2009-06-02
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
TRANSDERMAL DELIVERY OF BUPRENORPHINE PRODRUGS
Obligated Amount:
115025.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Trademarks

Serial Number:
78947827
Mark:
ALLTRANZ
Status:
Abandoned because the applicant filed an express abandonment. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Trademark, Service Mark
Application Filing Date:
2006-08-08
Mark Drawing Type:
3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S) /NUMBER(S)
Mark Literal Elements:
ALLTRANZ

Goods And Services

For:
Chemicals for use in the manufacture of pharmaceuticals in the nature of cannabinoids, prodrugs, opioid agonists, opioid antagonists and opioid agonist-antagonists
First Use:
2005-01-01
International Classes:
001 - Primary Class
Class Status:
ACTIVE
For:
Pharmaceutical preparations, both prescription and over-the-counter, for human and animal use, namely, allergy medication, analgesics, anti-inflammatories, antibiotics, antidiabetic preparations, antidiarrheal preparations, antibiotics, antifungal preparations, antihypertensives, antihistamines, ant...
First Use:
2005-01-01
International Classes:
005 - Primary Class
Class Status:
ACTIVE
For:
Drug delivery systems; microscopic needles for use in enhancing drug delivery through the skin; transdermal drug delivery patches sold without medication
First Use:
2005-01-01
International Classes:
010 - Primary Class
Class Status:
ACTIVE
For:
Pharmaceutical research and development services
First Use:
2005-01-01
International Classes:
042 - Primary Class
Class Status:
ACTIVE
Serial Number:
78947809
Mark:
ALLTRANZ
Status:
Abandoned because the applicant filed an express abandonment. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Trademark, Service Mark
Application Filing Date:
2006-08-08
Mark Drawing Type:
5 - AN ILLUSTRATION DRAWING WITH WORD(S)/LETTER(S)/NUMBER(S) IN STYLIZED FORM
Mark Literal Elements:
ALLTRANZ

Goods And Services

For:
Chemicals for use in the manufacture of pharmaceuticals in the nature of cannabinoids, prodrugs, opioid agonists, opioid antagonists and opioid agonist-antagonists
First Use:
2005-01-01
International Classes:
001 - Primary Class
Class Status:
ACTIVE
For:
Pharmaceutical preparations, both prescription and over-the-counter, for human and animal use, namely, allergy medication, analgesics, anti-inflammatories, antibiotics, antidiabetic preparations, antidiarrheal preparations, antibiotics, antifungal preparations, antihypertensives, antihistamines, ant...
First Use:
2005-01-01
International Classes:
005 - Primary Class
Class Status:
ACTIVE
For:
Drug delivery systems; microscopic needles for use in enhancing drug delivery through the skin; transdermal drug delivery patches sold without medication
First Use:
2005-01-01
International Classes:
010 - Primary Class
Class Status:
ACTIVE
For:
Pharmaceutical research and development services
First Use:
2005-01-01
International Classes:
042 - Primary Class
Class Status:
ACTIVE

Reviews Leave a review

This company hasn't received any reviews.

Financial Incentive

Program Program Status Average Hourly Wage Project Cost Incentive Amount Initial Jobs New Jobs Date of Action Approval Type
SBIR/STTR Inactive - $0 $500,000 - - 2014-04-01 Final
SBIR/STTR Inactive - $0 $150,000 - - 2012-10-01 Final
SBIR/STTR Inactive - $0 $150,000 - - 2011-10-01 Final
SBIR/STTR Inactive - $0 $100,000 - - 2007-12-01 Final

Sources: Kentucky Secretary of State